Published 19 March 2009, doi:10.1136/bmj.b773
Cite this as: BMJ 2009;338:b773

Research

Larval therapy for leg ulcers (VenUS II): randomised controlled trial

¹ Department of Health Sciences, University of York, York YO10 5DD, ² Biological Sciences, University of Warwick, ³ Micropathology Ltd, Coventry, ⁴ School of Healthcare, University of Leeds

Objective To compare the clinical effectiveness of larval therapy with a standard debridement technique (hydrogel) for sloughy or necrotic leg ulcers.

Design Pragmatic, three armed randomised controlled trial.

Setting Community nurse led services, hospital wards, and hospital outpatient leg ulcer clinics in urban and rural settings, United Kingdom.

Participants 267 patients with at least one venous or mixed venous and arterial ulcer with at least 25% coverage of slough or necrotic tissue, and an ankle brachial pressure index of 0.6 or more.

Interventions Loose larvae, bagged larvae, and hydrogel.

Main outcome measures The primary outcome was time to healing of the largest eligible ulcer. Secondary outcomes were time to debridement, health related quality of life (SF-12), bacterial load, presence of meticillin resistant Staphylococcus aureus, adverse events, and ulcer related pain (visual analogue scale, from 0 mm for no pain to 150 mm for worst pain imaginable).

Results Time to healing was not significantly different between the loose or bagged larvae group and the hydrogel group (hazard ratio for healing using larvae v hydrogel 1.13, 95% confidence interval 0.76 to 1.68; P=0.54). Larval therapy significantly reduced the time to debridement (2.31, 1.65 to 3.2; P<0.001). Health related quality of life and change in bacterial load over time were not significantly different between the groups. 6.7% of participants had MRSA at baseline. No difference was found between larval therapy and hydrogel in their ability to eradicate MRSA by the end of the debridement phase (75% (9/12) v 50% (3/6); P=0.34), although this comparison was underpowered. Mean ulcer related pain scores were higher in either larvae group compared with hydrogel (mean difference in pain score: loose larvae v hydrogel 46.74 (95% confidence interval 32.44 to 61.04), P<0.001; bagged larvae v hydrogel 38.58 (23.46 to 53.70), P<0.001).

Conclusions Larval therapy did not improve the rate of healing of sloughy or necrotic leg ulcers or reduce bacterial load compared with hydrogel but did significantly reduce the time to debridement and increase ulcer pain.

Trial registration Current Controlled Trials ISRCTN55114812 [controlled-trials.com] and National Research Register N0484123692.

© Dumville et al 2009
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Wrong treatment

Rolf Jelnes
BMJ 2009 338: b2063. [Extract] [Full Text]

Compression may be key

Anders Ternhag
BMJ 2009 338: b2064. [Extract] [Full Text]

Study authors respond to points in editorial

Nicky Cullum, Martin Bland, Jo Dumville, Cynthia Iglesias, Susan O’Meara, Marta Soares, David Torgerson, Andrea Nelson, and Gill Worthy
BMJ 2009 338: b2098. [Extract] [Full Text]

How to measure success in treating chronic leg ulcers

Joseph E Grey, David Leaper, and Keith Harding
BMJ 2009 338: b1434. [Extract] [Full Text]

Cost effectiveness analysis of larval therapy for leg ulcers

Marta O Soares, Cynthia P Iglesias, J Martin Bland, Nicky Cullum, Jo C Dumville, E Andrea Nelson, David J Torgerson, Gill Worthy on behalf of the VenUS II team
BMJ 2009 338: b825. [Abstract] [Full Text] [PDF]

Analysis of serial measurements in medical research.

J N Matthews, D G Altman, M J Campbell, and P Royston
BMJ 1990 300: 230-235. [Abstract] [PDF]

This article has been cited by other articles:

• Jelnes, R. (2009). Wrong treatment. BMJ 338: b2063-b2063 [Full text]  
• Ternhag, A. (2009). Compression may be key. BMJ 338: b2064-b2064 [Full text]  
• Cullum, N., Bland, M., Dumville, J., Iglesias, C., O'Meara, S., Soares, M., Torgerson, D., Nelson, A., Worthy, G. (2009). Study authors respond to points in editorial. BMJ 338: b2098-b2098 [Full text]  
• (2009). Making Your Skin Crawl Does Not Heal Ulcers Faster. Journal Watch Dermatology 2009: 5-5 [Full text]  
• Grey, J. E, Leaper, D., Harding, K. (2009). How to measure success in treating chronic leg ulcers. BMJ 338: b1434-b1434 [Full text]  
• Soares, M. O, Iglesias, C. P, Bland, J M., Cullum, N., Dumville, J. C, Nelson, E A., Torgerson, D. J, Worthy, G., on behalf of the VenUS II team, (2009). Cost effectiveness analysis of larval therapy for leg ulcers. BMJ 338: b825-b825 [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

Why?

Richard C Finn
bmj.com, 21 Mar 2009 [Full text]

Effectiveness of larval therapy in treatment of wounds

Dr Viera Scheibner
bmj.com, 23 Mar 2009 [Full text]

Virchow's cell theory in action?

Richard G Fiddian-Green
bmj.com, 23 Mar 2009 [Full text]

Flystrike in Australian merino sheep.

Richard G Fiddian-Green
bmj.com, 23 Mar 2009 [Full text]

Points to highlight

James A. W. Morgan
bmj.com, 23 Mar 2009 [Full text]

Wrong indication

Rolf Jelnes
bmj.com, 25 Mar 2009 [Full text]

Venous Ulcers and Maggots

Jon P Driver-Jowitt
bmj.com, 1 Apr 2009 [Full text]

Compression of venous leg ulcers

Anders Ternhag
bmj.com, 8 Apr 2009 [Full text]

Maggot Therapy: Apparently a good treatment despite poor study and inadequate analysis

Ronald A Sherman, et al.
bmj.com, 14 May 2009 [Full text]

VenUS Trialists Respond to Feedback

Nicky Cullum, et al.
bmj.com, 2 Jul 2009 [Full text]

Online poll

Find out more >>